ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3236

Socio-Demographic and Clinical Factors Influencing Generic and Disease-Specific Quality of Life in Patients with Systemic Lupus Erythematosus: Results of a Prospective Multicenter Study

Hervé Devilliers1, Jean-François Besancenot1, Sylvain Audia2, Bernard Bonnotte3, Francois Maurier4, Christiane Broussolle5, Nadine Magy-Bertrand6, Denis Wahl7, Jean-Loup Pennaforte8, Thierry Martin9, Olivier Aumaître10, Gilles Blaison11, Geraldine Muller1, Alexis Mathian12, Christine Binquet13 and Zahir Amoura14, 1Department of Internal Medicine and Systemic Diseases, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 2Department of Internal Medicine and Clinical Immunology, Hôpital François Mitterrand, CHU de Dijon; INSERM, UMR1098, University of Bourgogne Franche-Comté, FHU INCREASE, Dijon, France, 3Department of Internal Medicine and Clinical Immunology, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 4Department of Internal Medicine, HP Metz Belle Isle Hospital, Metz, France, 5Internal medicine department, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France, 6CHU Jean-Minjoz, Service de médecine interne et immunologie clinique, Besançon, France, 7CHU de Nancy, Vascular Medicine Division and Regional Competence Centre For Rare Vascular And Systemic Autoimmune Diseases; and UMR_S U1116 Research Unit, Nancy, France, 8Internal Medicine, Internal medicine departement, CHU de Reims, Reims, France, 9Internal medicine and clinical immunology departement, Strasbourg University Hospital, Strasbourg, France, 10CHU Pitié-Salpêtrière - Department of Internal Medicine 2. Referal center for SLE/APS, Paris, France, 11Internal medicine departement, Colmar Hospital, Colmar, France, 12Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, 13INSERM, CIC 1432, Clinical Epidemiology Unit, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 14Department of Internal Medicine 2. Referal center for SLE/APS, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Quality of life and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment VI: Quality of Life

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose:

To describe demographic, socio-economic and lupus-related factors associated with health-related quality of life (HRQOL) in systemic lupus erythematosus (SLE), as measured by 2 generic (Medical Outcome Study Short Form 36 [SF-36] and World Health Organisation Quality of life [WHOQOL] and 2 disease-specific (LupusQoL and SLEQOL) questionnaires recorded simultaneously.

Methods:

We conducted a prospective study involving SLE patients in 10 French tertiary hospitals. Disease activity was recorded by SELENA-SLEDAI (SS) and SS Flare Index Revised [SFI-R] alongside HRQoL and sociodemographic variables. Social precariousness was recorded using the validated “EPICES” questionnaire. Factors influencing HRQOL scores were studied using multivariate linear regression. All scores were transformed to a 0-100 scale (100 corresponding to the best QoL)

Results:

We included 336 patients, of whom 90% were women, mean age (SD) was 41(11.9), 51% were caucasian. Median (IQR) SLEDAI was 4 (0-8), and 39% of patients had at least a moderate flare. Social precariousness was recorded in 38% of patients, 62% had an education level greater than General Education Diploma and 31% were unemployed.

In multivariate analysis (figure 1), we found no effect of ethnicity on HRQOL. Social precariousness was strongly associated with the QoL score in all domains of generic and specific questionnaires, with mean estimated decreases ranging from -6.5 (SF-36 “Physical Functioning, p=0.02) to -17.84 (SLEQOL “Mood”, p<0.0001). The occurrence of an articular flare was also associated with a decrease in HRQOL in all domains (e.g. -19.6 in SF-36 “Role Physical” [p<0.0001] and -10 in SLEQOL “mood”, [p=0.01]), except for “psychological” and “environment” domains of the WHOQOL. Neuropsychiatric signs had a higher impact on specific questionnaires (figure 1). Obesity was associated with a significant decrease in HRQOL in SF-36 physical-related domains (-12.9, p=0.02 in “physical function” domain), but not in disease-specific questionnaires, except for the LupusQoL “Body Image” Domain (-8.57, p=0.02). Similarly, smoking was associated with a poorer HRQOL in some of the physical domains of generic questionnaires (-5.57 in WHOQOL “physical heath”, p=0.03), but not with disease-specific ones.

Conclusion: The social environment is highly associated with HRQOL in SLE patients, regardless of the instrument or domain. Disease-specific questionnaires may be more strongly correlated with some aspects of the disease and may be useful to distinguish the SLE-specific burden from other conditions such as obesity or smoking-related disease.

Figure 1: Summary of multivariate analysis. A red square indicates a significant independent association in multivariate linear regression (p<0.05) between a variable and at least one QoL domain score


Disclosure: H. Devilliers, None; J. F. Besancenot, None; S. Audia, None; B. Bonnotte, None; F. Maurier, Novartis Pharmaceutical Corporation, 3; C. Broussolle, None; N. Magy-Bertrand, None; D. Wahl, None; J. L. Pennaforte, None; T. Martin, None; O. Aumaître, None; G. Blaison, None; G. Muller, None; A. Mathian, None; C. Binquet, None; Z. Amoura, None.

To cite this abstract in AMA style:

Devilliers H, Besancenot JF, Audia S, Bonnotte B, Maurier F, Broussolle C, Magy-Bertrand N, Wahl D, Pennaforte JL, Martin T, Aumaître O, Blaison G, Muller G, Mathian A, Binquet C, Amoura Z. Socio-Demographic and Clinical Factors Influencing Generic and Disease-Specific Quality of Life in Patients with Systemic Lupus Erythematosus: Results of a Prospective Multicenter Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/socio-demographic-and-clinical-factors-influencing-generic-and-disease-specific-quality-of-life-in-patients-with-systemic-lupus-erythematosus-results-of-a-prospective-multicenter-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/socio-demographic-and-clinical-factors-influencing-generic-and-disease-specific-quality-of-life-in-patients-with-systemic-lupus-erythematosus-results-of-a-prospective-multicenter-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology